Ribon Therapeutics competitors and similar companiesClear all
Ribon Therapeutics's competitors and similar companies include OncoDNA, Innate Pharma, Entrinsic Bioscience and A2 Biotherapeutics.
 Ribon Therapeutics Ribon Therapeutics discovers and develops novel small molecule therapeutics for major unmet medical needs. |  OncoDNA OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients. |  Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. |  Entrinsic Bioscience Entrinsic Bioscience (formerly Entrinsic Health Solutions) is a company developing amino acid technology for the treatment of gastrointestinal disorders. |  A2 Biotherapeutics A2 Biotherapeutics is a biotechnology company that develops cell therapies for cancer patients. | |
Founding Date | Founding Date 2015 | Founding Date 2012 | Founding Date 1999 | Founding Date 2014 | Founding Date 2018 |
Type | Type Private | Type Private | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Cambridge, US HQ | Locations Charleroi, BE HQ | Locations Marseille, FR HQ Rockville, US | Locations Norwood, US HQ | Locations Agoura Hills, US HQ |
Employees | Employees 70 | Employees 66 | Employees 213 | Employees 353% decrease | Employees 1291% decrease |
Twitter followers | Twitter followers N/A | Twitter followers 674 | Twitter followers 4.1 k | Twitter followers 34 | Twitter followers N/A |
Employee Rating | Employee Rating 5 | Employee Rating 4.3 | Employee Rating 4.2 | Employee Rating N/A | Employee Rating 5 |
Funding | |||||
Latest funding round | Latest funding round $ 65m (over 1 year ago) | Latest funding round $ 20.6m (about 3 years ago) | Latest funding round N/A | Latest funding round $ 49m (almost 2 years ago) | Latest funding round $ 71.5m (over 2 years ago) |
Total funding raised | Total funding raised $ 65m | Total funding raised $ 29.8m | Total funding raised $ 94.1m | Total funding raised $ 58.2m | Total funding raised $ 128.5m |
For sources of this data, please see the company profile
View company profiles
OncoDNA
HQ
Charleroi, BE
Employees
66
OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients.
View companyInnate Pharma
HQ
Marseille, FR
Employees
213
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View companyEntrinsic Bioscience
HQ
Norwood, US
Employees
35↓ 3% decrease
Entrinsic Bioscience (formerly Entrinsic Health Solutions) is a company developing amino acid technology for the treatment of gastrointestinal disorders.
View companyA2 Biotherapeutics
HQ
Agoura Hills, US
Employees
129↓ 1% decrease
A2 Biotherapeutics is a biotechnology company that develops cell therapies for cancer patients.
View company